Over the years, the Imperial VPM meeting has been the catalyst for numerous technical innovations, collaborative initiatives, and landmark clinical trials. Its programme showcases state-of-the-art developments in the fundamental mechanisms of atherosclerosis, advances in disease diagnosis and risk stratification, and the latest findings from clinical trials. Extensive discussion sessions encourage critical evaluation of emerging evidence, foster collaboration between academia and industry, and help shape future research priorities to advance the field.

Description supplied by the event organiser.